BST2 and HIV infectious disease: Other compounds, such as IMB-LA, BST2-TM-P1 (contain BST-2 transmembrane domain sequences), and Y-39983 HCl combat HIV infection by competing with Vpu for binding to BST-2 (91, 92, 110).